<SEC-DOCUMENT>0001193125-23-240209.txt : 20230922
<SEC-HEADER>0001193125-23-240209.hdr.sgml : 20230922
<ACCEPTANCE-DATETIME>20230922112049
ACCESSION NUMBER:		0001193125-23-240209
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20230922
FILED AS OF DATE:		20230922
DATE AS OF CHANGE:		20230922

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ATS Corp /ATS
		CENTRAL INDEX KEY:			0001394832
		STANDARD INDUSTRIAL CLASSIFICATION:	GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569]
		IRS NUMBER:				980149239
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41713
		FILM NUMBER:		231270657

	BUSINESS ADDRESS:	
		STREET 1:		730 FOUNTAIN STREET NORTH
		STREET 2:		BUILDING #3
		CITY:			CAMBRIDGE
		STATE:			A6
		ZIP:			N3H 4R7
		BUSINESS PHONE:		519 653 6500

	MAIL ADDRESS:	
		STREET 1:		730 FOUNTAIN STREET NORTH
		STREET 2:		BUILDING #3
		CITY:			CAMBRIDGE
		STATE:			A6
		ZIP:			N3H 4R7

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ATS Automation Tooling Systems Inc.
		DATE OF NAME CHANGE:	20070328
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d448667d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">FORM&nbsp;6-K</FONT> </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF FOREIGN PRIVATE ISSUER
</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">PURSUANT&nbsp;TO&nbsp;RULE&nbsp;13a-16&nbsp;OR&nbsp;15d-16</FONT></FONT>
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of September 2023 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Commission&nbsp;File&nbsp;Number:&nbsp;001-41713</FONT> </B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>ATS CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>730 Fountain Street North </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Building 3 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cambridge,
Ontario N3H 4R7 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) </B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cover&nbsp;of&nbsp;Form&nbsp;20-F&nbsp;or&nbsp;Form&nbsp;40-F.</FONT></FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form&nbsp;20-F&#8194;&#9744;&#8195;&#8195;&#8195;&#8195; <FONT STYLE="white-space:nowrap">Form&nbsp;40-F&#8194;&#9746;</FONT> </P>
<P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d448667dex991.htm">Press release dated September&nbsp;22, 2023 </A></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ATS CORPORATION</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Registrant)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: September&nbsp;22, 2023</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&#8199;/s/ Stewart McCuaig</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&#8199;Name: Stewart McCuaig</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&#8199;Title: Vice President, General Counsel</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d448667dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:arial" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g448667grap.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:17pt; font-family:arial" ALIGN="center"><B>ATS To Acquire Biomedical Research&nbsp;&amp;
Life Sciences Water </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:17pt; font-family:arial" ALIGN="center"><B>Purification Equipment Provider Avidity Science </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:arial"><FONT COLOR="#262626">09/22/2023 </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">CAMBRIDGE, ON / CNW / - ATS Corporation (TSX: ATS) (NYSE: ATS) (&#147;<B>ATS</B>&#148; or the &#147;<B>Company</B>&#148;) a
leading automation solutions provider, today announced it has entered into a definitive agreement to acquire&nbsp;Avidity Science, LLC (&#147;<B>Avidity</B>&#148;), a growing designer and manufacturer of automated water purification solutions for
biomedical and life science applications, for US$195&nbsp;million (~C$265 million), representing 11.2x Avidity&#146;s projected calendar 2023 adjusted EBITDA<SUP STYLE="font-size:75%; vertical-align:top">1,2</SUP>, or 10.3x Avidity&#146;s projected
calendar 2023 synergy-adjusted EBITDA<SUP STYLE="font-size:75%; vertical-align:top">1,2</SUP>. The Company expects US$1.5&nbsp;million of cost and commercial synergies by year 3, and US$2.6&nbsp;million of cost and commercial synergies by year 5.
The acquisition is subject to customary post-closing adjustments. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">&#147;ATS works to support our customers in all
areas of life sciences from research, to drug discovery, right through to commercial production,&#148; said Andrew Hider, Chief Executive Officer of ATS Corporation. &#147;Avidity&#146;s capabilities provide researchers confidence in their data
during key stages of drug discovery, development and testing through their water purification and delivery systems.&#148; </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:arial" ALIGN="justify"><FONT
 COLOR="#262626">Founded in 1969 and based in Waterford, Wisconsin, Avidity offers automated watering systems for critical environments where strict variable controls and integrity are crucial. It serves a diverse global customer base of
pharmaceutical, biopharma, healthcare, government, and academic research facilities. In its financial year ended December&nbsp;31, 2022, Avidity generated revenues of US$81.9&nbsp;million, and a 20.4% adjusted EBITDA margin<SUP
STYLE="font-size:75%; vertical-align:top">2</SUP>. Approximately 40% of Avidity&#146;s revenue is reoccurring<SUP STYLE="font-size:75%; vertical-align:top">2</SUP> in nature, and includes the sale of consumables, SaaS, and aftermarket service and
support. Avidity employs approximately 380 skilled professionals across six facilities in the United States, United Kingdom, China, and Japan. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">&#147;This acquisition will bolster our value proposition for both new and existing customers, in addition to aligning well with
other accretive acquisitions we have made,&#148; added Prakash &#145;Cash&#146; Mahesh, Group Executive for ATS Life Sciences. &#147;It also supports our ATS Life Sciences purpose of positively impacting the quality of life for billions of people
around the world.&#148; </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:32%">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:arial"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>
Forecasted adjusted EBITDA as of December&nbsp;31, 2023. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial"><SUP STYLE="font-size:75%; vertical-align:top">2</SUP> Adjusted EBITDA is a
<FONT STYLE="white-space:nowrap">non-IFRS</FONT> measure, adjusted EBITDA margin is a <FONT STYLE="white-space:nowrap">non-IFRS</FONT> ratio, and reoccurring revenues is a supplementary financial measure. See
<FONT STYLE="white-space:nowrap">&#147;Non-IFRS</FONT> and Other Financial Measures&#148; and &#147;Reconciliation of <FONT STYLE="white-space:nowrap">Non-IFRS</FONT> Measures to IFRS Measures&#148; below. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g448667grap.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">The transaction is expected to close in the fourth calendar quarter of 2023,
pending completion of customary regulatory filings. ATS plans to fund the acquisition with cash and by drawing on its revolving credit facility, which will result in a pro forma leverage of 2.5x net debt to the last twelve months adjusted EBITDA<SUP
STYLE="font-size:75%; vertical-align:top">3,4</SUP>. </FONT></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:11pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626"><B>Conference call and webcast today </B></FONT></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:11pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">ATS will host a conference call and webcast at 8:30 a.m. Eastern Time today to discuss the acquisiton. The listen-only webcast can
be accessed live at www.atsautomation.com. The conference call can be accessed live by dialing <FONT STYLE="white-space:nowrap">(416)&nbsp;764-8688</FONT> or <FONT STYLE="white-space:nowrap">(888)&nbsp;390-0546</FONT> five minutes prior. A replay of
the conference will be available on the ATS website following the call. Alternatively, a telephone recording of the call will be available for one week (until midnight September&nbsp;29, 2023) by dialing (416)
<FONT STYLE="white-space:nowrap">764-8677</FONT> and entering passcode 128787 followed by the number sign. </FONT></P> <P STYLE="font-size:22pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626"><B>About ATS Corporation </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">ATS Corporation is an industry-leading automation solutions provider to many of the world&#146;s most successful companies. ATS
uses its extensive knowledge base and global capabilities in custom automation, repeat automation, automation products and value-added services including <FONT STYLE="white-space:nowrap">pre-automation</FONT> and after-sales services, to address the
sophisticated manufacturing automation systems and service needs of multinational customers in markets such as life sciences, food&nbsp;&amp; beverage, transportation, consumer products, and energy. Founded in 1978, ATS employs over 6,500 people at
more than 60 manufacturing facilities and over 80 offices in North America, Europe, Asia, and Oceania. The Company&#146;s common shares are traded on the Toronto Stock Exchange and the New York Stock Exchange under the symbol ATS. </FONT></P>
<P STYLE="font-size:20pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626"><B>About Avidity Science </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify">Avidity Science is a worldwide leader in water purification and delivery, control and monitoring and service solutions for the life science and
biomedical research communities. Since 1969, our mission has been to enable science to improve the quality of life. With operations in&nbsp;the United States,&nbsp;Europe, and&nbsp;Asia, we are a trusted partner to the global research community
through differentiated technology and support. For more information about our company, please visit&nbsp;<U><FONT STYLE="font-family:arial" COLOR="#0000ff">www.AvidityScience.com</FONT></U><FONT STYLE="font-family:arial">. </FONT></P>
<P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:32%">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:arial"><SUP STYLE="font-size:75%; vertical-align:top">3</SUP>
Net debt to adjusted EBITDA is a non-IFRS ratio, see &#147;See &#147;Non-IFRS and Other Financial Measures&#148; below. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial"><SUP STYLE="font-size:75%; vertical-align:top">4</SUP> Pro forma net debt to adjusted EBITDA includes figures for ATS as of July&nbsp;2, 2023, combined with Avidity
forecasted figures as of December&nbsp;31, 2023. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g448667grap.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626"><B>Forward-looking Statements </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">This press release contains certain statements that may constitute forward-looking information and forward-looking statements
within the meaning of applicable Canadian and United States securities laws (&#147;forward-looking statements&#148;). All such statements are made pursuant to the &#147;safe harbour&#148; provisions of Canadian provincial and territorial securities
laws and the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts regarding possible events, conditions, or results of operations that ATS believes, expects or
anticipates will or may occur in the future, including, but not limited to: the completion of the acquisition of Avidity; Avidity&#146;s projected adjusted EBITDA; the estimated future synergies; ATS&#146;s value proposition; and the projected debt
leverage ratio. </FONT></P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">Forward-looking statements are inherently subject to significant known and unknown risks,
uncertainties, and other factors that may cause the actual results, performance, or achievements of ATS, or developments in ATS&#146; business or in its industry, to differ materially from the anticipated results, performance, achievements, or
developments expressed or implied by such forward-looking statements. Important risks, uncertainties, and factors that could cause actual results to differ materially from expectations expressed in the forward-looking statements include, but are not
limited to, the impact of regional or global conflicts; general market performance including capital market conditions and availability and cost of credit; performance of the markets that ATS serves; industry challenges in securing the supply of
labour, materials, and, in certain jurisdictions, energy sources such as natural gas; impact of inflation; interest rate changes; foreign currency and exchange risk; the relative strength of the Canadian dollar; risks related to customer
concentration; risks related to a recession, slowdown, and/or sustained downturn in the economy; impact of factors such as increased pricing pressure, increased cost of energy and supplies, and delays in relation thereto, and possible margin
compression; the regulatory and tax environment; the emergence of new infectious diseases and pandemics, including the potential resurgence of <FONT STYLE="white-space:nowrap">COVID-19</FONT> and/or new strains of
<FONT STYLE="white-space:nowrap">COVID-19</FONT> and collateral consequences thereof, including the disruption of economic activity, volatility in capital and credit markets, and legislative and regulatory responses; the effect of events involving
limited liquidity, defaults, <FONT STYLE="white-space:nowrap">non-performance</FONT> or other adverse developments that affect financial institutions, transaction counterparties, or other companies in the financial services industry generally, or
concerns or rumours about any events of these kinds or other similar risks, that have in the past and may in the future lead to market-wide liquidity problems; energy shortages and global prices increases; that closing is delayed or prohibited as a
result of the inability to complete closing conditions; that Avidity does not meet its projected adjusted EBITDA targets; that the expected synergies are not realized; that the acquisition does not bolster ATS&#146;s value proposition for new and/or
existing customers; the debt leverage ratio is not achieved as projected; and other risks and uncertainties detailed from time to time in ATS&#146; filings with securities regulators, including, without limitation, the risk factors described in
ATS&#146; annual information form for the fiscal year ended March&nbsp;31, 2023, which are available on the System for Electronic Document Analysis and Retrieval (&#147;SEDAR+&#148;) at www.sedarplus.com and on the U.S. Securities Exchange
Commission&#146;s Electronic Data Gathering, Analysis and Retrieval System (&#147;EDGAR&#148;) at www.sec.gov. ATS has attempted to identify important factors that could cause actual results to materially differ from current expectations, however,
there may be other factors that cause actual results to differ materially from such expectations. </FONT></P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">Forward-looking
statements are necessarily based on a number of estimates, factors, and assumptions regarding, among others, management&#146;s current plans, estimates, projections, beliefs and opinions, the future performance and results of the Company&#146;s
business and operations; the ability of ATS to execute on its business objectives; and general economic and political conditions, and global events, including the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g448667grap.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">Forward-looking statements included in this press release are only provided to
understand management&#146;s current expectations relating to future periods and, as such, are not appropriate for any other purpose. Although ATS believes that the expectations reflected in such forward-looking statements are reasonable, such
statements involve risks and uncertainties, and ATS cautions you not to place undue reliance upon any such forward-looking statements, which speak only as of the date they are made. ATS does not undertake any obligation to update forward-looking
statements contained herein other than as required by law. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626"><B><FONT STYLE="white-space:nowrap">Non-IFRS</FONT> and
Other Financial Measures </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify">Throughout this press release management refers to certain <FONT STYLE="white-space:nowrap">non-IFRS</FONT>
measures, <FONT STYLE="white-space:nowrap">non-IFRS</FONT> ratios and supplementary financial measures. The term &#147;adjusted EBITDA&#148; is a <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measure, &#147;adjusted EBITDA margin&#148;, and
&#147;net debt to adjusted EBITDA&#148; are <FONT STYLE="white-space:nowrap">non-IFRS</FONT> ratios, and &#147;reoccurring revenue&#148; a supplementary financial measure, all of which do not have any standardized meaning prescribed within
International Financial Reporting Standards (&#147;IFRS&#148;) and therefore may not be comparable to similar measures presented by other companies. Such measures should not be considered in isolation or as a substitute for measures of performance
prepared in accordance with IFRS. Adjusted EBITDA is defined as net income excluding income tax expense, net finance costs, depreciation and amortization before items excluded from management&#146;s internal analysis of operating results, such as
amortization expense of acquisition-related intangible assets, acquisition-related transaction and integration costs, restructuring charges, the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT>
adjustment on stock-based compensation and certain other adjustments which would be <FONT STYLE="white-space:nowrap">non-recurring</FONT> in nature (&#147;adjustment items&#148;). Adjusted EBITDA margin is an expression of the Company&#146;s
adjusted EBITDA as a percentage of revenues. Net debt to adjusted EBITDA is the ratio of the net debt of the Company (cash and cash equivalents less bank indebtedness, long-term debt, and lease liabilities) to adjusted EBITDA. Reoccurring revenues
are defined as contracts to provide ancillary products and services associated with equipment sales and contracts with customers who purchase <FONT STYLE="white-space:nowrap">non-customized</FONT> ATS products at regular intervals. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify">Adjusted EBITDA and adjusted EBITDA margin are used by the Company to evaluate the performance of its operations. Management believes that adjusted
EBITDA is an important indicator of the Company&#146;s ability to generate operating cash flows to fund continued investment in its operations. The adjustment items used by management to arrive at these metrics are not considered to be indicative of
the business&#146; ongoing operating performance. Management uses net debt to adjusted EBITDA as a measurement of leverage of the Company. Reoccurring revenues are used by the Company to understand the revenue portfolio of the Company. Management
believes that ATS shareholders and potential investors in ATS use these additional IFRS measures and <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures in making investment decisions and measuring operational results. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g448667grap.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><FONT COLOR="#262626"><B><U>Reconciliation of <FONT STYLE="white-space:nowrap">Non-IFRS</FONT> Measures to GAAP
Measures</U> </B></FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">The following is a reconciliation of adjusted EBITDA to net income for the twelve months ended
May&nbsp;31, 2023. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><FONT COLOR="#262626">&#8201;&#8201;(In thousands of U.S. dollars)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="right"><FONT COLOR="#262626"><B>Twelve&nbsp;Months&#8201;<BR>Ended&#8201;</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial" ALIGN="right"><FONT COLOR="#262626"><B>May&nbsp;31, 2023&#8201;</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626"><B>&#8201;&#8201;Adjusted
EBITDA</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"><FONT COLOR="#262626"><B>&#8195;&#8195;$</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000" ALIGN="right"><FONT COLOR="#262626"><B>16,499&#8201;</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"><FONT COLOR="#262626"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">&#8201;&#8201;Less: management adjustments</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top"><FONT COLOR="#262626">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT COLOR="#262626">1,996&#8201;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT COLOR="#262626">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">&#8201;&#8201;Less:
depreciation and amortization expense</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT COLOR="#262626">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT COLOR="#262626">8,186&#8201;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT COLOR="#262626">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626"><B>&#8201;&#8201;Earnings from
operations</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"><FONT COLOR="#262626"><B>&#8195;&#8195;$</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000" ALIGN="right"><FONT COLOR="#262626"><B> 6,317&#8201;</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"><FONT COLOR="#262626"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">&#8201;&#8201;Less: net finance costs</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top"><FONT COLOR="#262626">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT COLOR="#262626">4,458&#8201;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT COLOR="#262626">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">&#8201;&#8201;Less: provisions
for income taxes</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT COLOR="#262626">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT COLOR="#262626">480&#8201;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT COLOR="#262626">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT
 COLOR="#262626"><B>&#8201;&#8201;Net income</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000"><FONT COLOR="#262626"><B>&#8195;&#8195;$</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000" ALIGN="right"><FONT COLOR="#262626"><B> 1,379&#8201;</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000"><FONT COLOR="#262626"><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626"><B>For more information, contact:</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">David Galison</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">Head of Investor Relations</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">ATS Corporation</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">730 Fountain Street North</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">Cambridge, ON, N3H 4R7</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">(519) <FONT STYLE="white-space:nowrap">653-6500</FONT></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">dgalison@atsautomation.com</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626"><B>For general media inquiries, contact:</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">Matthew Robinson</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT
 COLOR="#262626">Director, Corporate Communications</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">ATS Corporation</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">730 Fountain Street North</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">Cambridge, ON, N3H 4R7</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT
 COLOR="#262626">(519) <FONT STYLE="white-space:nowrap">653-6500</FONT></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial" ALIGN="justify"><FONT COLOR="#262626">mrobinson@atsautomation.com</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><FONT COLOR="#262626">SOURCE: ATS Corporation </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g448667grap.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g448667grap.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$H17AI9@  34T *@    @ !0$2  ,
M   !  $   $[  (    ;   (5H=I  0    !   (<IR=  $    V   0ZNH<
M  <   @,    2@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M     %1H86YG851H:7)U<&%T:&D@4F%J86=O<&%L    !9 #  (    4   0
MP) $  (    4   0U)*1  (    #,S4  )*2  (    #,S4  .H<  <   @,
M   (M      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                         #(P
M,C,Z,#DZ,C(@,3@Z,#$Z,3< ,C R,SHP.3HR,B Q.#HP,3HQ-P   %0 : !A
M &X 9P!A %0 : !I '( =0!P &$ = !H &D ( !2 &$ :@!A &< ;P!P &$
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M5(1-D2!(8%[?,0B >I K\!_$/B>^\5:_?ZK>7$TEYJEU+>7#>8>9)'+L>O\
M>9OTK\<\._#6IQ1[>JJOLJ=-I)\M^9N^EDU9K2^KW1V<3<5+*94X\G,Y7TO:
MUK>3ZW^X_HF/B;3_ /H(6'XW"_XT?\)-I_\ T$-/_P# A?\ &OYS1<3?\]IO
M^_AH:YEQ_KIO^_A_QK]+_P")=_\ J._\D?\ \F?*?\1,?_0/_P"3?\ _HR_X
M2;3_ /H(:?\ ^!"_XU)::]9ZA*T<%U;32* =L4H<@9QGC^=?SD?:IATFE]/O
MG_&OU+_X(5? N/0O@MX@^(ERTKZAXHOGTVUW_,(K6V;!*GJ"\QDS[1KZ5\AQ
MOX1T^',L>8U<7S.ZBH\EKM_]O/I=[=#VN'^-*F9XM8:-'EZMWO9+Y(^\Y[E;
M>/=(RQ]LLV!FH3K-J/\ EYM_^_@KY0_X*-_%>1[_ $KP;9R_NX0-1O2'.2YR
M(D/TP6/U6OE\3-CB23';YC7SF1^'M3,,'#%U*O)S:I<M].][K<]?,.)(X>NZ
M*A>WF?J?_;MKG_CZM_\ OX*/[=M?^?JW_P"_@K\L/.D_YZ2?]]FFF>0'_62?
M]]&O8_XA2O\ H)_\E_\ MCB_UN?2G^)^J/\ ;MI_S]6__?P5:CD65 RL&5AD
M$'J*_+;PCX;O?'OBG3=%LY)/M.K7"6L9+$A2Y +'V R?P-?I_H6F0Z-I%K9V
MX*V]G$D,8/7:J@#],5\9Q5PS')YTZ2J\TI7>UK+[WN>WD^:RQJE)QY4BZ[E8
MMW?'I63+X_T6UGDBFUC28I(VVLK7D:LI[@@G((]*\D_X*.?MF6'[ 7[$?Q'^
M+=]':W$G@_27GT^TN&*QWU_(1%:0-@@[7G>-3M.<$D=*_B3\=?$76_B)XSU7
MQ!K.JWFHZQKEW+J%]<R2'?<3RN9)'/N69C7RA[)_>-_PL/0<<:YH_P#X&Q_X
MU?TW5(M5A66"2.:%AE9(SN1^<<,./\^QK^!7^U+K/_'Q/_W\-?T[?\&;_P"U
MNWQ?_P""??BCX8ZEJ!N-4^$>OLMM"Y+/%INH;[B'GN/M"WOT [ B@#]?JR;G
MQQI&GW<EO=:KI=O<1'#Q2W2(Z9 (!4G(X(Z^M:P.17\=_P#P<CW<T'_!;#X^
M>7-*@_M.P.%<@?\ (*LJ /Z^/^%AZ#_T'-'_ / V/_&C_A8>@_\ 0<T?_P #
M8_\ &OX(SJ=S_P _$_\ W\-)_:ES_P _$_\ W\- '][O_"P]!_Z#FC_^!L?^
M-'_"P]!_Z#FC_P#@;'_C7\$7]J7/_/Q/_P!_#1_:ES_S\3_]_#0!_>[_ ,+#
MT'_H.:/_ .!L?^-26'C32=5O!;VNJ:;=3,"5CAN4D=@.O .?6OX'O[4N?^?B
M?_OX:_2C_@TTO9I_^"TW@<232N/["UKAG)_Y<I* /ZS:KWVH1Z?;33320PPV
MZEY))6V(B@9))/ 'O7S'_P %>O\ @IWX=_X)0_L?WWQ*UC39/$&J75['HV@:
M-'.(/[2OY$D=%=^J1*D;N[ ,0%P!DBOY6_\ @I)_P6@^.W_!3_Q@UQX^\4R:
M;X8BPMGX3T&6:ST.U .0QA+L9I<D_O9F=N<#:N% !_5A\4O^"R?[*OP7O9K3
MQ%^T!\*K:^M7,<]K:^((+^X@<=5>.W+LI'H0*P?!_P#P7?\ V/?'6I?9+']H
M?X9PS>NHZE_9T7_?RX6-/UK^+K#"@@@4 ?WM?#/XK^&?C-X5M]=\(^(M!\5:
M)=?ZG4-'U"*^M9<==LL3,I_ UT-?PD?LV?M:?$S]D'QY#XD^&7COQ/X&UB)@
MS3Z3?/ MP 00DT8.R:,D#*2*RGN#7](O_! G_@Y+G_X*4_$?_A4/Q6T71_#O
MQ0-E+>:1J>E%X].\2+" TL7DR.S17(CW2X4F-U20@1[0I /UPD8I&Q R0.!Z
MU";S*Y!C'U;K4B_\>P_B^7OSFOS7_;>_8>\(7WQA_;%U[2/@_H$VH7G[/:7^
MB:C8>%8VN;C7[D^+!=S6LT<19M0E4V@D>,F9P8-Q/R4 ?I(MVQ5<JOO[\9X_
MSVJQ7Y=^ O#OQ0O/VP?V:_ OB#PWXVDT+]F;QA)H,7BJ>SF-KXNL]0\-:PUC
M>,^S:6M;."TM[F0D+]KO'48.%K]1* "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU J]S);JDF> !:-W:OZ+*_AU_P"":O[7UQ^P9^W3\,?BQ#')-;>$=;BFU&%
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MTEI=%5'W5:>"1E'976OHR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTY_;IL?V3/\ @I=#X-UR3[/H/QLLD\-+,<[+?45?S;%F'?>^^ <<-<J>%#$
M']6E?B+_ ,'N?_)I/P5_[&^[_P#2,U^W$+,\>6&#7XC_ /![G_R:3\%?^QON
M_P#TC- '\WM?U*?\&:'_ "B=US_LH6I?^DEA7\M=?U*?\&:'_*)W7/\ LH6I
M?^DEA0!^M%(XRC?3O2TC?=/TH _'+_@H%_P=\_#?]F#QUXG\#^!?A7XW\6>-
M/"^IW&D7Q\0A-#TV">%BCX&9;A]K C:T46>H/0U^<?BK_@[N_:B\=?'WPAXB
MN)/"OAWP7X?U:"[U#PIX?T[R8=<M4E!D@GN+AIIMSQY3<C(H.&V=J]W_ .#L
M[_@CGJ7@KXE:G^U3X'M4G\+^(I;:W\<6$$9\W2KXKY*:@ !M\B;;$DG((F8,
M<^:2GX<2##?@* /[G?V0OVZ?A3^W5\-+'Q5\+_&F@^*;*ZMHKBXM+6]A?4-*
M:1=WDW<"L7@E'0JX'3C(P3ZTTZHK,WRJHR2> !7\#G@[Q[KGPZ\0PZOX=UC5
M- U6W_U5YIMW):W$7^[(A##IV-=SXT_;;^,WQ'\/MI/B'XM_$S7=+92C6>H>
M)[VYMV4\$%'E*D>Q% 'WM_P=M?'+X>_'#_@J+%)X#U/1=<G\.^%;/2=?U#2Y
MX[B&6_2:=S"TL9*M)%$\:-R2I&PX*$+^75/>=GC"\87VKT?]D+]D_P :?MP?
MM$>&/A?\/]-_M/Q3XJNA;VRNQ2&UC +RW$SX.R&*-6=VP2%4X!. 0#^H+_@T
MKTC4M._X(N^"YKU)EM=0\0:S<6!?HT O'C)7V\Z.8?4&OTPKR?\ 8:_94TC]
MB+]D+X=_"C19%N++P-HL&G-=+'Y?VZ<#=/<%>QEF:60CUD->L4 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXJ_Z&+P__P!^Y?\ "OM$)BCRA7I1\0,Z245-:?W8_P"1A_J[@;WY7]Y\7?\
M#M#Q5_T,7A__ +]R_P#Q-'_#M'Q5_P!#%X?_ ._<O^%?:/E"CRQ1_P 1 SK_
M )^+_P !C_D'^KN!_E_$\[_9G^!R_ +X90Z-)+#<7\TS7-[/%GRY9#A1MR 0
MH15 !]*]$3I04S3@,5\EB<55Q%65>L[RDVVSV*-&%*"IP5DC\6?^"T'_  ;>
M?''_ (*K?MSZQ\4+7XD?#70?#\>FVFBZ%I]XMZUU;6D"ECYI2(KN::6=_E)
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M>Y\):Y-JMS-K(G9)D>W,05/*1CG/)S@8K]!** /YJ_\ B"3^./\ T5[X4_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M  KXO_D2@#]WJ*_"'_B.)\,?]&Z>(/\ PKXO_D2C_B.)\,?]&Z>(/_"OB_\
MD2@#]WJ*_"'_ (CB?#'_ $;IX@_\*^+_ .1*/^(XGPQ_T;IX@_\ "OB_^1*
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M0#_P[_\ ]R4?\."_^KU/^"@'_AW_ /[DK] ** /S_P#^'!?_ %>I_P % /\
MP[__ -R4?\."_P#J]3_@H!_X=_\ ^Y*_0"B@#\__ /AP7_U>I_P4 _\ #O\
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M#\__ /AP7_U>I_P4 _\ #O\ _P!R4?\ #@O_ *O4_P""@'_AW_\ [DK] **
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M0#_P[_\ ]R4?\."_^KU/^"@'_AW_ /[DK] ** /S_P#^'!?_ %>I_P % /\
MP[__ -R4?\."_P#J]3_@H!_X=_\ ^Y*_0"B@#\__ /AP7_U>I_P4 _\ #O\
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M?C?X6_MOQ!XE_P"$9\?Z]I7]KZ[=_;-5U3R-2N(OM-W/A?-N)-N^23 W.S'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -E?
MRUS[@?GQ7\Z/[;?_  :,_M(?M+_MG?%SXC:%XV^!]IHOC[QKK/B33X+_ %C5
M$NH;>\OIKF))533G59 DBA@K, 0<,1S110!YC_Q!6?M3?]#]^S__ .#O5_\
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M $/W[/\ _P"#O5__ )6444 '_$%9^U-_T/W[/_\ X.]7_P#E91_Q!6?M3?\
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/+G&3P2B@#]U**** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
